Immune checkpoint inhibitors, such as PD-1/PD-L1 and CTLA-4 inhibitors, increase immune-mediated destruction of tumor cells by interrupting tumor inhibition of T-cell-mediated apoptosis [119]. This evidence concerns the gene PDCD1 and neoplasm.